{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-042932","form_type":"8-K","ticker":"DNA","cik":"0001830214","company_name":"Ginkgo Bioworks Holdings, Inc.","filed_at":"2026-06-12T21:00:14+00:00","discovered_at":"2026-06-12T21:02:00.231051+00:00","generated_at":"2026-06-12T21:04:22.329630+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"confidence":"high","headline":"All six director nominees elected, Deloitte ratified, say-on-pay approved at Ginkgo 2026 annual meeting","bullets":["Shareholders present: 39.5M Class A and 8.4M Class B shares, representing 77.15% of combined voting power.","All six directors elected: Jason Kelly and Reshma Shetty (Class B vote), Ross Fubini, Christian Henry, Sri Kosuri, Harry E. Sloan (single class).","Ratification of Deloitte & Touche as auditor for FY2026 approved: 119.5M for, 267k against, 3.8M abstentions.","Advisory vote to approve executive compensation passed: 95.1M for, 12.5M against, 4.2M abstentions (broker non-votes 11.8M)."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-042932","json":"https://secwatch.observer/filing/0001628280-26-042932.json","markdown":"https://secwatch.observer/filing/0001628280-26-042932.md","text":"https://secwatch.observer/filing/0001628280-26-042932.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026042932/0001628280-26-042932-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026042932/dna-20260611.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T21:04:22.329630+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4826c23d37991a155cd543c49ef7a2e73934a6a9","claim":"Ginkgo Bioworks Holdings, Inc. shareholders approved Advisory vote to approve the compensation of the Company’s named executive officers.","evidence_excerpt":"Pursuant to the foregoing vote, the compensation of the Company’s named executive officers was approved on an advisory basis.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026042932/0001628280-26-042932-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"}],"fact_type":"shareholder_vote"},{"claim_id":"8c3f6ff3c8a82c3f46f4d973943ff5d35f4147e8","claim":"Ginkgo Bioworks Holdings, Inc. shareholders approved Election of six nominees to serve as directors at the 2026-06-11 meeting.","evidence_excerpt":"Pursuant to the foregoing votes, the six nominees listed above were elected to serve on the Company’s Board of Directors.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026042932/0001628280-26-042932-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-11"}],"fact_type":"shareholder_vote"},{"claim_id":"9d180e1ef1b33faf098804a883c2e23c63479ec6","claim":"Ginkgo Bioworks Holdings, Inc. shareholders approved Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-12-31 meeting.","evidence_excerpt":"Pursuant to the foregoing vote, the ratification of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 was approved.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026042932/0001628280-26-042932-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-12-31"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}